Assessment of preference for hormonal treatment-related health states among patients with breast cancer

Xing Yu Tan, Maung Maung Aung, Mei Ing Ngai, Feng Xie, Yu Ko

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objectives: 1) To obtain preference scores from patients with breast cancer in Singapore for different stages of breast cancer and hormonal therapy-related adverse effects, and 2) to determine the association of patients' demographic and clinical characteristics with those preference scores. Methods: A total of 22 health states were used to elicit preference values from 64 patients with breast cancer. At each interview, 14 health states were randomly selected and rated by the patient using the visual analogue scale and standard gamble methods to derive health state preference scores, which were recalibrated to the scale of 0 (death) and 1 (perfect health). Results: Mean adjusted visual analogue scale scores ranged from 0.25 (no recurrence with ischemic cerebrovascular events) to 0.82 (no recurrence with no adverse effects). Mean adjusted standard gamble scores ranged from 0.31 (distant recurrence with chemotherapy-related adverse effects) to 0.80 (no recurrence with no adverse effects). Adverse effects ischemic cerebrovascular events and spine fracture resulted in the greatest decline in health state preference scores. Age, ethnicity, education level, and prior chemotherapy were associated with preference scores. Having children was not found to be associated with the preference scores. Conclusions: Taking into account disease progression and hormonal therapy-related adverse effects as well as their impact on health-related quality of life, this study quantifies patients' preference for various breast cancer-related health states. The findings offer valuable information for future cost-utility analysis of breast cancer treatments.

Original languageEnglish
Pages (from-to)27-32
Number of pages6
JournalValue in Health Regional Issues
Volume3
Issue number1
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Breast Neoplasms
Health
Recurrence
Patient Preference
Visual Analog Scale
Therapeutics
Drug Therapy
Singapore
Cost-Benefit Analysis
Disease Progression
Breast cancer
Health state
Spine
Quality of Life
Demography
Interviews
Education
Standard gamble
Visual analogue scale
Chemotherapy

Keywords

  • Breast cancer
  • Preference
  • Standard gamble
  • VAS

ASJC Scopus subject areas

  • Health Policy
  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Economics, Econometrics and Finance (miscellaneous)

Cite this

Assessment of preference for hormonal treatment-related health states among patients with breast cancer. / Tan, Xing Yu; Aung, Maung Maung; Ngai, Mei Ing; Xie, Feng; Ko, Yu.

In: Value in Health Regional Issues, Vol. 3, No. 1, 2014, p. 27-32.

Research output: Contribution to journalArticle

Tan, Xing Yu ; Aung, Maung Maung ; Ngai, Mei Ing ; Xie, Feng ; Ko, Yu. / Assessment of preference for hormonal treatment-related health states among patients with breast cancer. In: Value in Health Regional Issues. 2014 ; Vol. 3, No. 1. pp. 27-32.
@article{527bdc78157548638c0f1f42dc2233ad,
title = "Assessment of preference for hormonal treatment-related health states among patients with breast cancer",
abstract = "Objectives: 1) To obtain preference scores from patients with breast cancer in Singapore for different stages of breast cancer and hormonal therapy-related adverse effects, and 2) to determine the association of patients' demographic and clinical characteristics with those preference scores. Methods: A total of 22 health states were used to elicit preference values from 64 patients with breast cancer. At each interview, 14 health states were randomly selected and rated by the patient using the visual analogue scale and standard gamble methods to derive health state preference scores, which were recalibrated to the scale of 0 (death) and 1 (perfect health). Results: Mean adjusted visual analogue scale scores ranged from 0.25 (no recurrence with ischemic cerebrovascular events) to 0.82 (no recurrence with no adverse effects). Mean adjusted standard gamble scores ranged from 0.31 (distant recurrence with chemotherapy-related adverse effects) to 0.80 (no recurrence with no adverse effects). Adverse effects ischemic cerebrovascular events and spine fracture resulted in the greatest decline in health state preference scores. Age, ethnicity, education level, and prior chemotherapy were associated with preference scores. Having children was not found to be associated with the preference scores. Conclusions: Taking into account disease progression and hormonal therapy-related adverse effects as well as their impact on health-related quality of life, this study quantifies patients' preference for various breast cancer-related health states. The findings offer valuable information for future cost-utility analysis of breast cancer treatments.",
keywords = "Breast cancer, Preference, Standard gamble, VAS",
author = "Tan, {Xing Yu} and Aung, {Maung Maung} and Ngai, {Mei Ing} and Feng Xie and Yu Ko",
year = "2014",
doi = "10.1016/j.vhri.2013.12.002",
language = "English",
volume = "3",
pages = "27--32",
journal = "Value in Health Regional Issues",
issn = "2212-1099",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Assessment of preference for hormonal treatment-related health states among patients with breast cancer

AU - Tan, Xing Yu

AU - Aung, Maung Maung

AU - Ngai, Mei Ing

AU - Xie, Feng

AU - Ko, Yu

PY - 2014

Y1 - 2014

N2 - Objectives: 1) To obtain preference scores from patients with breast cancer in Singapore for different stages of breast cancer and hormonal therapy-related adverse effects, and 2) to determine the association of patients' demographic and clinical characteristics with those preference scores. Methods: A total of 22 health states were used to elicit preference values from 64 patients with breast cancer. At each interview, 14 health states were randomly selected and rated by the patient using the visual analogue scale and standard gamble methods to derive health state preference scores, which were recalibrated to the scale of 0 (death) and 1 (perfect health). Results: Mean adjusted visual analogue scale scores ranged from 0.25 (no recurrence with ischemic cerebrovascular events) to 0.82 (no recurrence with no adverse effects). Mean adjusted standard gamble scores ranged from 0.31 (distant recurrence with chemotherapy-related adverse effects) to 0.80 (no recurrence with no adverse effects). Adverse effects ischemic cerebrovascular events and spine fracture resulted in the greatest decline in health state preference scores. Age, ethnicity, education level, and prior chemotherapy were associated with preference scores. Having children was not found to be associated with the preference scores. Conclusions: Taking into account disease progression and hormonal therapy-related adverse effects as well as their impact on health-related quality of life, this study quantifies patients' preference for various breast cancer-related health states. The findings offer valuable information for future cost-utility analysis of breast cancer treatments.

AB - Objectives: 1) To obtain preference scores from patients with breast cancer in Singapore for different stages of breast cancer and hormonal therapy-related adverse effects, and 2) to determine the association of patients' demographic and clinical characteristics with those preference scores. Methods: A total of 22 health states were used to elicit preference values from 64 patients with breast cancer. At each interview, 14 health states were randomly selected and rated by the patient using the visual analogue scale and standard gamble methods to derive health state preference scores, which were recalibrated to the scale of 0 (death) and 1 (perfect health). Results: Mean adjusted visual analogue scale scores ranged from 0.25 (no recurrence with ischemic cerebrovascular events) to 0.82 (no recurrence with no adverse effects). Mean adjusted standard gamble scores ranged from 0.31 (distant recurrence with chemotherapy-related adverse effects) to 0.80 (no recurrence with no adverse effects). Adverse effects ischemic cerebrovascular events and spine fracture resulted in the greatest decline in health state preference scores. Age, ethnicity, education level, and prior chemotherapy were associated with preference scores. Having children was not found to be associated with the preference scores. Conclusions: Taking into account disease progression and hormonal therapy-related adverse effects as well as their impact on health-related quality of life, this study quantifies patients' preference for various breast cancer-related health states. The findings offer valuable information for future cost-utility analysis of breast cancer treatments.

KW - Breast cancer

KW - Preference

KW - Standard gamble

KW - VAS

UR - http://www.scopus.com/inward/record.url?scp=84897415108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897415108&partnerID=8YFLogxK

U2 - 10.1016/j.vhri.2013.12.002

DO - 10.1016/j.vhri.2013.12.002

M3 - Article

VL - 3

SP - 27

EP - 32

JO - Value in Health Regional Issues

JF - Value in Health Regional Issues

SN - 2212-1099

IS - 1

ER -